Lyell Immunopharma
A biotechnology company developing cellular immunotherapies for treating cancer.
2
Funding Rounds
$179.0m
Money raised
Overview
A biotechnology company developing cellular immunotherapies for treating cancer.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri** Kl****** | - | - | |
| St** Ri***** | - | - | - |
| Cr***** Ma***** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri** Kl****** | - | - | |
| El******* Na*** | - | - | |
| Ot** Br***** | - | - | |
| Wi***** J. Ri***** | - | - | - |
| Ca******* J. Fr****** | - | - | - |
| Ha** Bi**** | - | - | - |
| Ly** Se*** | - | - | - |
| Ro**** Ne**** | - | - | linkedin twitter facebook |
| Li* Ho**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Lyell Immunopharma has raised a total of $179m in funding over 2 rounds.
Key Insights:
- Lyell Immunopharma funding round, February 2019: $179m
Lyell Immunopharma funding round, February 2019
$179m
Industries
Lyell Immunopharma is active in the following industries:
- Biopharmaceutical
- Cancer
- Cell therapy
- Immunotherapy
- Oncology
- Technology
- Biology
- Biotechnology
- Internal medicine
- Healthcare
- Regenerative medicine
- Medicine
- T cell